M&G plc’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.6M Buy
157,963
+16,353
+12% +$1.43M 0.07% 181
2026
Q1
$12.7M Buy
141,610
+18,408
+15% +$1.69M 0.07% 179
2025
Q4
$11.1M Buy
123,202
+15,737
+15% +$1.49M 0.06% 206
2025
Q3
$10.6M Buy
107,465
+495
+0.5% +$49K 0.06% 206
2025
Q2
$9.73M Buy
106,970
+16,389
+18% +$1.58M 0.05% 209
2025
Q1
$10.2M Sell
90,581
-4,063
-4% -$435K 0.05% 192
2024
Q4
$10M Sell
94,644
-5,892
-6% -$632K 0.06% 208
2024
Q3
$10.9M Buy
100,536
+21,251
+27% +$2.32M 0.04% 201
2024
Q2
$8.64M Buy
79,285
+23,245
+41% +$2.74M 0.03% 228
2024
Q1
$7.4M Buy
+56,040
New +$7M 0.03% 260

Other funds holding ZBH

M&G plc's ZBH Position: Q2 2026 in Review

M&G plc increased its Zimmer Biomet (ZBH) stake by 12% in Q2 2026, buying an estimated $1.43M and bringing the position to 157,963 shares worth $13.6M. The position accounts for 0.07% of the portfolio, ranked #181.

M&G plc first reported a position in ZBH in Q1 2024 and has held it in 10 quarters since. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • M&G plc held 157,963 shares of Zimmer Biomet worth $13.6M as of Q2 2026.
  • M&G plc bought 16,353 Zimmer Biomet shares in Q2 2026, an estimated $1.43M.
  • Zimmer Biomet made up 0.07% of M&G plc's portfolio in Q2 2026, its #181 holding.
  • M&G plc first reported a position in Zimmer Biomet in Q1 2024 and has held it in 10 quarters since.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on M&G plc's 13F filing for Q2 2026, filed 6 Aug 2026.